这是一篇来自已证抗体库的有关
人类 IDH1的综述,是根据29篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IDH1 抗体。
IDH1 同义词: HEL-216; HEL-S-26; IDCD; IDH; IDP; IDPC; PICD
Dianova
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, H09)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 1). Front Neurosci (2020) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, H09)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2a). Neurosurgery (2018) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, H09)被用于被用于免疫组化在人类样本上浓度为1:50 (图 2o). Brain Pathol (2018) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Diavona, H09)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:40 (表 1). Biochim Biophys Acta Proteins Proteom (2017) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, H09)被用于被用于免疫组化在人类样本上 (图 1a). Turk Neurosurg (2017) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, DIA-H09)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 1). Brain Pathol (2017) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, DIA-H09)被用于被用于免疫组化在人类样本上 (图 3c). Sci Rep (2016) ncbi |
小鼠 单克隆(H09) | - 免疫细胞化学; 人类; 1:50; 图 2
- 免疫印迹; 人类; 1:500; 图 9
| Dianova IDH1抗体(Dianova, DIA-H09)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 2) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 9). PLoS ONE (2016) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, H09)被用于被用于免疫组化在人类样本上浓度为1:20 (图 1c). Pituitary (2016) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, H09)被用于被用于免疫组化在人类样本上浓度为1:40 (表 2). Am J Surg Pathol (2016) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, DIA-H09)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6). Proc Natl Acad Sci U S A (2015) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, H09)被用于被用于免疫组化在人类样本上浓度为1:50 (表 1). Pathol Int (2016) ncbi |
小鼠 单克隆(H09) | | Dianova IDH1抗体(Dianova, DIA-H09)被用于被用于免疫印迹在人类样本上. Acta Neuropathol (2014) ncbi |
北京傲锐东源
小鼠 单克隆(OTI24A2) | - 免疫组化-石蜡切片; 人类; 1:150; 图 1
| 北京傲锐东源 IDH1抗体(Origene Technologies, OTI24A2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (图 1). BMC Cancer (2019) ncbi |
小鼠 单克隆(OTI2H9) | | 北京傲锐东源 IDH1抗体(Origene, TA500610)被用于被用于免疫印迹在人类样本上. Cancer Discov (2014) ncbi |
武汉三鹰
domestic rabbit 多克隆 | | 武汉三鹰 IDH1抗体(Proteintech, 12332-1-AP)被用于被用于免疫印迹在人类样本上 (图 5g). Cell Stem Cell (2017) ncbi |
domestic rabbit 多克隆 | | 武汉三鹰 IDH1抗体(Proteintech, 12332-1-AP)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5i). Nat Chem Biol (2016) ncbi |
domestic rabbit 多克隆 | | 武汉三鹰 IDH1抗体(ProteinTech, 12332-1-AP)被用于被用于免疫印迹在人类样本上 (表 1). elife (2016) ncbi |
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR12296) | | 艾博抗(上海)贸易有限公司 IDH1抗体(Epitomics, 8057-1)被用于被用于免疫印迹在人类样本上 (图 s8). Oncotarget (2015) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D2H1) | | 赛信通(上海)生物试剂有限公司 IDH1抗体(CST, 8137)被用于被用于免疫印迹在人类样本上 (图 2d). Genes Dev (2017) ncbi |
domestic rabbit 单克隆(D2H1) | | 赛信通(上海)生物试剂有限公司 IDH1抗体(CST, 8137)被用于被用于免疫印迹在人类样本上 (图 5a). Oncotarget (2017) ncbi |
domestic rabbit 单克隆(D2H1) | | 赛信通(上海)生物试剂有限公司 IDH1抗体(Cell Signaling, 8137)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). JCI Insight (2016) ncbi |
domestic rabbit 单克隆(D2H1) | | 赛信通(上海)生物试剂有限公司 IDH1抗体(Cell Signaling, 8137)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 st1). Nat Commun (2016) ncbi |
domestic rabbit 单克隆(D2H1) | - 免疫细胞化学; 人类; 1:400; 图 2
- 免疫印迹; 人类; 1:1000; 图 9
| 赛信通(上海)生物试剂有限公司 IDH1抗体(Cell Signaling Tech, 8137)被用于被用于免疫细胞化学在人类样本上浓度为1:400 (图 2) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 9). PLoS ONE (2016) ncbi |
domestic rabbit 单克隆(D2H1) | | 赛信通(上海)生物试剂有限公司 IDH1抗体(cell Signaling Tech, 8137S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s11). PLoS Genet (2015) ncbi |
domestic rabbit 单克隆(D2H1) | | 赛信通(上海)生物试剂有限公司 IDH1抗体(Cell Signaling Technology, 8137)被用于被用于免疫印迹在人类样本上浓度为1:1000. Nat Commun (2015) ncbi |
domestic rabbit 单克隆(D2H1) | | 赛信通(上海)生物试剂有限公司 IDH1抗体(Cell Signaling Tech, 8137)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2). Nat Cell Biol (2015) ncbi |
默克密理博中国
小鼠 单克隆(HMab-1) | - 免疫组化-冰冻切片; 人类; 1:20; 图 2a
| 默克密理博中国 IDH1抗体(Merck Millipore, MABC171)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:20 (图 2a). J Histochem Cytochem (2018) ncbi |
MBL International
| | MBL International IDH1抗体(Medical & Biological Laboratories, D299-3)被用于被用于免疫组化在人类样本上浓度为1:200. Brain Tumor Pathol (2016) ncbi |
| | MBL International IDH1抗体(MBL, D299?C3)被用于被用于免疫组化在人类样本上. J Neurosurg (2014) ncbi |
Han Y, Wang W, Yang Y, Sun Y, Xiao G, Tian Q,
et al. Amide Proton Transfer Imaging in Predicting Isocitrate Dehydrogenase 1 Mutation Status of Grade II/III Gliomas Based on Support Vector Machine. Front Neurosci. 2020;14:144
pubmed 出版商
Bi C, Liu M, Rong W, Wu F, Zhang Y, Lin S,
et al. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study. BMC Cancer. 2019;19:213
pubmed 出版商
Pratt D, Dominah G, Lobel G, Obungu A, Lynes J, Sanchez V,
et al. Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma. Neurosurgery. 2018;:
pubmed 出版商
Hira V, Wormer J, Kakar H, Breznik B, van der Swaan B, Hulsbos R,
et al. Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins. J Histochem Cytochem. 2018;66:155-173
pubmed 出版商
Morgan M, Rickels R, Collings C, He X, Cao K, Herz H,
et al. A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. Genes Dev. 2017;31:2003-2014
pubmed 出版商
Kitazawa S, Ebara S, Ando A, Baba Y, Satomi Y, Soga T,
et al. Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors. Oncotarget. 2017;8:28922-28938
pubmed 出版商
Zhu Z, Li C, Zeng Y, Ding J, Qu Z, Gu J,
et al. PHB Associates with the HIRA Complex to Control an Epigenetic-Metabolic Circuit in Human ESCs. Cell Stem Cell. 2017;20:274-289.e7
pubmed 出版商
Ronellenfitsch M, Oh J, Satomi K, Sumi K, Harter P, Steinbach J,
et al. CASP9 germline mutation in a family with multiple brain tumors. Brain Pathol. 2018;28:94-102
pubmed 出版商
Le Rhun E, Duhamel M, Wisztorski M, Gimeno J, Zairi F, Escande F,
et al. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification. Biochim Biophys Acta Proteins Proteom. 2017;1865:875-890
pubmed 出版商
Rahman S, Ji X, Zimmerman L, Li M, Harris B, Hoeksema M,
et al. The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. JCI Insight. 2016;1:e88814
pubmed 出版商
Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A,
et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852
pubmed 出版商
Hacisalihoglu P, Kucukodaci Z, Gundogdu G, Bilgic B. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients. Turk Neurosurg. 2017;27:682-689
pubmed 出版商
Bielle F, Ducray F, Mokhtari K, Dehais C, Adle Biassette H, Carpentier C,
et al. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas. Brain Pathol. 2017;27:567-579
pubmed 出版商
Oktay Y, Ãœlgen E, Can Ã, Akyerli C, Yüksel Å, Erdemgil Y,
et al. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep. 2016;6:27569
pubmed 出版商
Rosiak K, Smolarz M, Stec W, Peciak J, Grzela D, Winiecka Klimek M,
et al. IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis. PLoS ONE. 2016;11:e0154726
pubmed 出版商
Casar Borota O, Øystese K, Sundstrom M, Melchior L, Popovic V. A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas. Pituitary. 2016;19:407-14
pubmed 出版商
Liu L, Shah S, Fan J, Park J, Wellen K, Rabinowitz J. Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage. Nat Chem Biol. 2016;12:345-52
pubmed 出版商
Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian X,
et al. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016;40:847-56
pubmed 出版商
Richarson A, Scott D, Zagnitko O, Aza Blanc P, Chang C, Russler Germain D. Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation. elife. 2016;5:e10860
pubmed 出版商
Okamoto S, Nitta M, Maruyama T, Sawada T, Komori T, Okada Y,
et al. Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas. Brain Tumor Pathol. 2016;33:129-36
pubmed 出版商
Wille C, Nawandar D, Henning A, Ma S, Oetting K, Lee D,
et al. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch. Proc Natl Acad Sci U S A. 2015;112:E7257-65
pubmed 出版商
Yamaguchi M, Komori T, Nakata Y, Yagishita A, Morino M, Isozaki E. Multinodular and vacuolating neuronal tumor affecting amygdala and hippocampus: A quasi-tumor?. Pathol Int. 2016;66:34-41
pubmed 出版商
Aviner R, Shenoy A, Elroy Stein O, Geiger T. Uncovering Hidden Layers of Cell Cycle Regulation through Integrative Multi-omic Analysis. PLoS Genet. 2015;11:e1005554
pubmed 出版商
Lin A, Abbas S, Kim S, Ortega M, Bouamar H, Escobedo Y,
et al. D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2. Nat Commun. 2015;6:7768
pubmed 出版商
Ma S, Jiang B, Deng W, Gu Z, Wu F, Li T,
et al. D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth. Oncotarget. 2015;6:8606-20
pubmed
Fong M, Zhou W, Liu L, Alontaga A, Chandra M, Ashby J,
et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol. 2015;17:183-94
pubmed 出版商
Liu Y, Gilbert M, Kyprianou N, Rangnekar V, Horbinski C. The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells. Acta Neuropathol. 2014;128:723-32
pubmed 出版商
Ishikawa E, Muragaki Y, Yamamoto T, Maruyama T, Tsuboi K, Ikuta S,
et al. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma. J Neurosurg. 2014;121:543-53
pubmed 出版商
Elhammali A, Ippolito J, Collins L, Crowley J, Marasa J, Piwnica Worms D. A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor. Cancer Discov. 2014;4:828-39
pubmed 出版商